Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
INFI

Infinity Pharmaceuticals

$1.24

0.06 (5.08%)

, BMY

Bristol-Myers

$65.24

-0.21 (-0.32%)

07:44
01/13/20
01/13
07:44
01/13/20
07:44
Hot Stocks
Infinity Pharmaceuticals offers 2020 IPI-549 development and financial guidance »

Infinity Pharmaceuticals…

INFI

Infinity Pharmaceuticals

$1.24

0.06 (5.08%)

BMY

Bristol-Myers

$65.24

-0.21 (-0.32%)

RHHBY

Roche

$0.00

(0.00%)

RCUS

Arcus Biosciences

$10.04

-0.13 (-1.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jan

  • 27

    Jan

  • 30

    Jan

  • 06

    Feb

  • 10

    Feb

  • 13

    Feb

  • 10

    Mar

  • 25

    Mar

BLUE

Bluebird Bio

$90.55

-0.45 (-0.49%)

05:50
01/13/20
01/13
05:50
01/13/20
05:50
Hot Stocks
Bluebird Bio announces launch of ZYNTEGLO in Germany »

bluebird bio announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jan

EXEL

Exelixis

$18.31

-0.31 (-1.66%)

, BMY

Bristol-Myers

$65.24

-0.21 (-0.32%)

16:47
01/12/20
01/12
16:47
01/12/20
16:47
Hot Stocks
Exelixis outlines key priorities, anticipated milestones for 2020-2021 »

Exelixis (EXEL) announced…

EXEL

Exelixis

$18.31

-0.31 (-1.66%)

BMY

Bristol-Myers

$65.24

-0.21 (-0.32%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jan

  • 27

    Jan

  • 30

    Jan

  • 06

    Feb

  • 10

    Feb

  • 13

    Feb

  • 10

    Mar

  • 25

    Mar

NKTR

Nektar

$25.60

4.07 (18.90%)

, BMY

Bristol-Myers

$65.37

-0.08 (-0.12%)

12:50
01/10/20
01/10
12:50
01/10/20
12:50
Recommendations
Nektar, Bristol-Myers analyst commentary at Goldman Sachs »

Goldman keeps Sell on…

NKTR

Nektar

$25.60

4.07 (18.90%)

BMY

Bristol-Myers

$65.37

-0.08 (-0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

  • 14

    Jan

  • 27

    Jan

  • 06

    Feb

  • 10

    Feb

  • 13

    Feb

  • 10

    Mar

  • 25

    Mar

GBT

Global Blood Therapeutics

$84.05

0.18 (0.21%)

, TEVA

Teva

$9.13

0.11 (1.22%)

12:25
01/10/20
01/10
12:25
01/10/20
12:25
Conference/Events
Cantor Fitzgerald biotech analyst to hold an analyst/industry conference call »

Biotech Analyst Young,…

GBT

Global Blood Therapeutics

$84.05

0.18 (0.21%)

TEVA

Teva

$9.13

0.11 (1.22%)

BMY

Bristol-Myers

$65.25

-0.2 (-0.31%)

PRX

Now private

$0.00

(0.00%)

NVS

Novartis

$94.20

-0.55 (-0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

  • 22

    Jan

  • 27

    Jan

  • 06

    Feb

  • 10

    Feb

  • 13

    Feb

  • 26

    Feb

  • 10

    Mar

  • 25

    Mar

NKTR

Nektar

$25.67

4.14 (19.23%)

, BMY

Bristol-Myers

$65.18

-0.27 (-0.41%)

11:38
01/10/20
01/10
11:38
01/10/20
11:38
Recommendations
Nektar, Bristol-Myers analyst commentary at Piper Sandler »

Nektar update with…

NKTR

Nektar

$25.67

4.14 (19.23%)

BMY

Bristol-Myers

$65.18

-0.27 (-0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

  • 14

    Jan

  • 27

    Jan

  • 06

    Feb

  • 10

    Feb

  • 13

    Feb

  • 10

    Mar

  • 25

    Mar

NKTR

Nektar

$21.53

-0.22 (-1.01%)

, BMY

Bristol-Myers

$65.45

1.57 (2.46%)

09:04
01/10/20
01/10
09:04
01/10/20
09:04
Recommendations
Nektar, Bristol-Myers analyst commentary at H.C. Wainwright »

Amended Nektar, Bristol…

NKTR

Nektar

$21.53

-0.22 (-1.01%)

BMY

Bristol-Myers

$65.45

1.57 (2.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

  • 14

    Jan

  • 27

    Jan

  • 06

    Feb

  • 10

    Feb

  • 13

    Feb

  • 10

    Mar

  • 25

    Mar

NKTR

Nektar

$21.53

-0.22 (-1.01%)

, BMY

Bristol-Myers

$65.45

1.57 (2.46%)

07:01
01/10/20
01/10
07:01
01/10/20
07:01
Hot Stocks
Nektar, Bristol-Myers amend strategic pact for bempegaldesleukin plus Opdivo »

Nektar Therapeutics…

NKTR

Nektar

$21.53

-0.22 (-1.01%)

BMY

Bristol-Myers

$65.45

1.57 (2.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

  • 14

    Jan

  • 27

    Jan

  • 06

    Feb

  • 10

    Feb

  • 13

    Feb

  • 10

    Mar

  • 25

    Mar

GBT

Global Blood Therapeutics

$83.87

1.96 (2.39%)

, TEVA

Teva

$9.02

0.1 (1.12%)

04:55
01/10/20
01/10
04:55
01/10/20
04:55
Conference/Events
Cantor Fitzgerald biotech analyst to hold an analyst/industry conference call »

Biotech Analyst Young,…

GBT

Global Blood Therapeutics

$83.87

1.96 (2.39%)

TEVA

Teva

$9.02

0.1 (1.12%)

BMY

Bristol-Myers

$65.45

1.57 (2.46%)

PRX

Now private

$0.00

(0.00%)

NVS

Novartis

$94.75

0.28 (0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

  • 22

    Jan

  • 27

    Jan

  • 06

    Feb

  • 10

    Feb

  • 13

    Feb

  • 26

    Feb

  • 10

    Mar

  • 25

    Mar

ABAC

Ticker changed to BIQI

$0.00

(0.00%)

, AMGN

Amgen

$238.24

0.22 (0.09%)

08:03
01/09/20
01/09
08:03
01/09/20
08:03
Conference/Events
Goldman Sachs to hold a conference »

12th Annual Healthcare…

ABAC

Ticker changed to BIQI

$0.00

(0.00%)

AMGN

Amgen

$238.24

0.22 (0.09%)

BLUE

Bluebird Bio

$91.70

1.645 (1.83%)

BMRN

BioMarin

$84.73

0.515 (0.61%)

BMY

Bristol-Myers

$63.88

-0.06 (-0.09%)

CRSP

Crispr Therapeutics

$62.53

2.11 (3.49%)

GS

Goldman Sachs

$237.77

2.29 (0.97%)

HUM

Humana

$374.77

8.14 (2.22%)

TFX

Teleflex

$379.59

0.26 (0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jan

  • 09

    Jan

  • 10

    Jan

  • 13

    Jan

  • 15

    Jan

  • 15

    Jan

  • 15

    Jan

  • 27

    Jan

  • 29

    Jan

  • 05

    Feb

  • 06

    Feb

  • 10

    Feb

  • 13

    Feb

  • 13

    Feb

  • 26

    Feb

  • 10

    Mar

  • 25

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.